Elegrobart
Elegrobart is an immunoglobulin G1-κ monoclonal antibody targeting the human insulin-like growth factor 1 receptor (IGF1R) . Elegrobart is promising for research of diseases associated with abnormal IGF1R signaling, especially thyroid eye disease[1].
Product Specifications
CAS Number
2832924-76-0
UNSPSC
12352203
Target
IGF-1R
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[Elegrobart]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
245845-APC 100 µL
ETV1 (Ets Variant 1, DKFZp781L0674, ER81, MGC104699, MGC120533, MGC120534) (APC)
Sign In for Pricing
View Details 
LV720680 1.0 µg DNA
CCT4P2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details